anti-HER2 antibodies (cancer)

Unknown Manufacturer

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

ANTI-CD3 ANTIBODIES AND METHODS OF USE THEREOF
EP 4291578 A4Applicant: ADAGENE PTE LTDPriority: 2021
CN
EP
US
WO
6 publications
Antibody-induced apoptosis
US 7354583 B2Applicant: AMGEN INCPriority: 2001
US
6 publications
RK POLYPEPTIDE RADIOPHARMACEUTICAL TARGETING HER2, AND PREPARATION METHOD THEREFOR
EP 3978033 A4Applicant: UNIV BEIJINGPriority: 2019
CN
EP
US
WO
5 publications
METHODS OF TREATING CANCER USING ANTI-HER2 ANTIBODY-DRUG CONJUGATES AND ANTI-PD-1 ANTIBODIES
EP 4777154 A1Applicant: REMEGEN CO LTDPriority: 2023
CN
EP
US
WO
5 publications
TREATMENT OF CANCER WITH HER2XCD3 BISPECIFIC ANTIBODIES IN COMBINATION WITH ANTI-HER2 MAB
EP 3938403 A1Applicant: HOFFMANN LA ROCHEPriority: 2019
CN
EP
US
WO
4 publications
ANTI-HER-2/TROP-2 CONSTRUCTS AND USES THEREOF
EP 4281484 C0Applicant: HANGZHOU BAIKAI BIOPHARMACEUTICAL CO LTDPriority: 2021
CN
EP
US
WO
4 publications
METHODS OF TREATING CANCER WITH ANTI-HER2 BIPARATOPIC ANTIBODIES
EP 4401774 A4Applicant: ZYMEWORKS BC INCPriority: 2021
CN
EP
US
WO
4 publications
Combination Therapy Using Anti-EGFR and Anti-HER2 Antibodies
US 2009214541 A1Applicant: INSTUT NAT DE LA SANTE ET DE LPriority: 2006
CN
US
4 publications
METHOD FOR TREATING BREAST CANCER
EP 3533468 A1Applicant: ADC THERAPEUTICS SAPriority: 2012
CN
EP
US
3 publications
USE OF QUINAZOLINE-BASED TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF CANCERS WITH NRG1 FUSIONS
EP 4097140 A4Applicant: UNIV TEXASPriority: 2020
EP
US
WO
3 publications